ACM
NERV icon

Aquatic Capital Management’s Minerva Neurosciences NERV Stock Holding History

Aquatic Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-275
Closed -$2K – 1368
2021
Q4 		$2K Buy
+275
New +$2.59K ﹤0.01% 1045

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aquatic Capital Management's NERV Position: Q1 2022 in Review

Aquatic Capital Management sold out of Minerva Neurosciences (NERV) in Q1 2022, closing a stake of 275 shares — an estimated $2K sold.

Aquatic Capital Management first reported a position in NERV in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 33 funds tracked by Wall St. Rank hold NERV as of Q1 2022.

  • Aquatic Capital Management reported no remaining Minerva Neurosciences position as of Q1 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 275 Minerva Neurosciences shares in Q1 2022, an estimated $2K.
  • Aquatic Capital Management first reported a position in Minerva Neurosciences in Q4 2021 and held it in 1 quarter.
  • Aquatic Capital Management's Minerva Neurosciences position peaked at $2K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2022.

Based on Aquatic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.